Your browser doesn't support javascript.
loading
Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases.
Ugai, Tomotaka; Haruki, Koichiro; Harrison, Tabitha A; Cao, Yin; Qu, Conghui; Chan, Andrew T; Campbell, Peter T; Akimoto, Naohiko; Berndt, Sonja; Brenner, Hermann; Buchanan, Daniel D; Chang-Claude, Jenny; Fujiyoshi, Kenji; Gallinger, Steven J; Gunter, Marc J; Hidaka, Akihisa; Hoffmeister, Michael; Hsu, Li; Jenkins, Mark A; Milne, Roger L; Moreno, Victor; Newcomb, Polly A; Nishihara, Reiko; Pai, Rish K; Sakoda, Lori C; Slattery, Martha L; Sun, Wei; Amitay, Efrat L; Alwers, Elizabeth; Thibodeau, Stephen N; Toland, Amanda E; Van Guelpen, Bethany; Woods, Michael O; Zaidi, Syed H; Potter, John D; Giannakis, Marios; Song, Mingyang; Nowak, Jonathan A; Phipps, Amanda I; Peters, Ulrike; Ogino, Shuji.
Affiliation
  • Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Haruki K; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Harrison TA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Cao Y; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Qu C; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri, USA.
  • Chan AT; Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Campbell PT; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Akimoto N; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Berndt S; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Brenner H; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Buchanan DD; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Chang-Claude J; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Fujiyoshi K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Gallinger SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Gunter MJ; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hidaka A; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Hoffmeister M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hsu L; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Jenkins MA; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Milne RL; Genetic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Moreno V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Newcomb PA; University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany.
  • Nishihara R; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Pai RK; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Sakoda LC; Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Slattery ML; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Sun W; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Amitay EL; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Alwers E; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Thibodeau SN; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Toland AE; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Van Guelpen B; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Woods MO; Oncology Data Analytics Program, Catalan Institute of Oncology (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Zaidi SH; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Potter JD; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Giannakis M; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • Song M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Nowak JA; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Phipps AI; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Peters U; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Ogino S; Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Am J Gastroenterol ; 118(4): 712-726, 2023 04 01.
Article in En | MEDLINE | ID: mdl-36707929
ABSTRACT

INTRODUCTION:

Early-onset colorectal cancer diagnosed before the age of 50 years has been increasing. Likely reflecting the pathogenic role of the intestinal microbiome, which gradually changes across the entire colorectal length, the prevalence of certain tumor molecular characteristics gradually changes along colorectal subsites. Understanding how colorectal tumor molecular features differ by age and tumor location is important in personalized patient management.

METHODS:

Using 14,004 cases with colorectal cancer including 3,089 early-onset cases, we examined microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF mutations in carcinomas of the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum and compared early-onset cases with later-onset cases.

RESULTS:

The proportions of MSI-high, CIMP-high, and BRAF -mutated early-onset tumors were lowest in the rectum (8.8%, 3.4%, and 3.5%, respectively) and highest in the ascending colon (46% MSI-high; 15% CIMP-high) or transverse colon (8.6% BRAF -mutated) (all Ptrend <0.001 across the rectum to ascending colon). Compared with later-onset tumors, early-onset tumors showed a higher prevalence of MSI-high status and a lower prevalence of CIMP-high status and BRAF mutations in most subsites. KRAS mutation prevalence was higher in the cecum compared with that in the other subsites in both early-onset and later-onset tumors ( P < 0.001). Notably, later-onset MSI-high tumors showed a continuous decrease in KRAS mutation prevalence from the rectum (36%) to ascending colon (9%; Ptrend <0.001), followed by an increase in the cecum (14%), while early-onset MSI-high cancers showed no such trend.

DISCUSSION:

Our findings support biogeographical and pathogenic heterogeneity of colorectal carcinomas in different colorectal subsites and age groups.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2023 Type: Article Affiliation country: United States